Skip to content

A clinical study to see the efficacy of Utkleshana, shodhana and Shamana basti(enema) In Amavata

A clinical study ro evaluate the combined effect of utkleshana, doshahara and shamana basti in the management of amavata vis-a-vis Rheumatoid arthritis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031461
Enrollment
30
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M054- Rheumatoid myopathy with rheumatoid arthritis

Interventions

Intervention1: Utkleshana, Doshahara(Shodana) and Samshamana basti.: 1.POORVAKARMA Deepana â?? pachana With 5gm of vaishwanara churna TID & Agnitundi vati 500mg BD till3-7 days or till nirama laxanas

Sponsors

Dr Shyam B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling diagnostic criteria 2.Rheumatoid arthritis with less than 5 years of chronicity. (Parameters in ACR-EULAR criteria : Duration of symptoms,joint distribution, acute phase reactants) 3.Subjects who are fit for basti karma. 4.Subjects who are ready to give written consent for the study

Exclusion criteria

Exclusion criteria: 1.Subjects with other systemic disorders which interfere with the intervention. 2.Rheumatoid arthritis with deformities like Swan neck deformity, Boutonniere deformity, z-shaped deformity,Rheumatic nodules. 3.Pregnant & Lactating women. 4.Subjects suffering from rectal pathologies like haemorrhoids, fissure, and rectal prolapse.

Design outcomes

Primary

MeasureTime frame
Reduction in the signs and symptoms of Disease Amavata.Timepoint: 2 weeks

Secondary

MeasureTime frame
Nature and presentation of the disease can be known.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Shyam B

Government Ayurveda Medical College and Hospital, Mysuru

kulkarnidrvarsha@gmail.com7676848402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026